Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...

At 2 years, Black and white patients who received Lucentis for the treatment of diabetic macular edema achieved similar levels of best corrected visual acuity, according to a study published in JAMA ...